News Releases

The University of Arizona College of Medicine and the Arizona Cancer Center will host a colorectal cancer symposium Nov. 5 to 7 at the Hilton Tucson El Conquistador resort featuring a panel of internationally recognized speakers.

In the first successful surgery of its kind in Southern Arizona, Jonathan C. Daniel, MD, a University of Arizona thoracic surgeon, performed a highly complex procedure to treat malignant mesolthelioma.

The Arizona Cancer Center honors Arizona-based Goodmans Interior Structures, the first company in the state awarded the CEO Gold Standard accreditation for its commitment to reducing cancer risk of employees and their families.

Extended therapy with the drug Avastin may help women with newly diagnosed advanced ovarian cancer, according to a Phase III study by the Gynecologic Oncology Group (GOG).

The grant will fund the development and evaluation of a new program to train chiropractors, acupuncturists and massage therapists in effective ways to help their patients and clients quit tobacco.

Arizona Cancer Center patients were among the 676 individuals who participated in a worldwide drug trial that, for the first time, demonstrated increased survival for patients with metastatic melanoma.

Eugene W. Gerner, PhD, professor of Cell Biology and Anatomy, Director of the Arizona Cancer Center’s Gastrointestinal (GI) Cancer program and BIO5 Institute member, talks about the research that garnered him the 2010 Technology Innovation Award.

Leslie Gunatilaka, PhD, a member of the Arizona Cancer Center's Therapeutic Development Program, used a new quick-growing technique to produce a water-soluble form of a plant compound that combats cancer and encourages the survival of healthy cells.